David Hofer, Managing Director
Cannabis Market Insights and Prime Listings for Strategic Investors
On October 8th and 9th over 2,000 cannabis investors and operators will be gathering in Chicago for the latest insights and opportunities in the cannabis markets across the U.S.
We’ve arranged for you to register for the conference with a 20% discount.
Just CLICK HERE and the 20% Discount will be applied directly to your ticket purchase price.
We’re anticipating that the conference will provide insights and access to buyers and sellers in the markets that are of most interest. Both myself and Managing Partner Cam Horan will be at the conference to discuss specific Buy and Sell Opportunities from our most active markets, where we have opportunities available like these:
OHIO
Since Adult-Use sales began in August, Ohio has racked up $22.5M in sales for the first two weeks of the month alone.
What we have Under Contract:
A processor in the Cleveland area and Dispensaries in Akron, Oxford, and Toledo.
What we have Available:
Level II Cultivation, Processor, & Approved Dispensary Location & License
Lease or purchase real estate. Currently 13K sf on 8.5 acres. 24K sf addition plan.
Processor
High-capacity 12K sf facility. White labeling experience. OMMCP certified, FDA compliant.
CONNECTICUT
With cannabis sales now over $300M since Adult-Use legalized last year, more volume is projected as product selection at the Provisioning Centers is allowed to increase.
What’s Available:
Adult-Use Provisioning Center Available – One of 12 Adult-Use Licenses in the State
Located in former popular retail facility with a traffic count near freeway entrance of 130K cars/day. Property is currently being built out. Opening scheduled for November.
ILLINOIS
Where Cannabis sales hit the year-to-date $1B mark already in July, we have:
Three BLS-5 Dispensaries (Under Contract)
A package of Three additional BLS-5 Conditional Licenses Available $4.5M
ARIZONA
The state set a record of $1.5B cannabis sales in 2023, and is running well ahead of that pace this year.
What we have Available:
Dual License
Dispensary With Dual License
NEW JERSEY
New Jersey cannabis sales of a record $1B are already on a pace to exceed that in 2024.
What we’ve moved there recently: Dispensaries in Evesham and Rockaway. Approved Dispensary locations and licenses in Mt Laurel, Trenton and Vorhees.
What’s still Available:
Limited-License Approved Dispensary Locations & Licenses
Fort Lee
Cap of two in the city. 4.7K sf, 26 dedicated parking spaces.
Vernon
One of the only dispensaries in NJ ski country. Cap of two.
Jefferson
Recreation destination near state’s largest lake. Site plan is gas & grass. Open to bids.
Approved Dispensary Locations & Licenses
Absecon
$1.5 million ask, built out.
Somerset
Price includes real estate. Annual license. Not built out. $2.5M ask.
Approved Dispensary Locations & Licenses
SOLD: Gloucester City, Maple Shade, Maywood, North Plainfield
Available: Atlantic City, Carney’s Point, Edgewater Park, Evesham, Franklin Township, Highland Park, Jersey City, Mount Laurel, Red Bank, Secaucus, Shamong, South Hackensack, Voorhees, Williamstown
Dispensaries Operating or Opening Soon
Camden
Drive-through near performing arts centers. Opened fall 2023.
Newark
Ramping $6M annual revenue.
Jersey City
Has smoking lounge. $6.75M ask.
Cultivation & Processor
Central NJ. 15K sf canopy with plants in the ground. Purchase or partner
FLORIDA
License Option
Florida has the largest medical marijuana sales in the country. By state law Florida is behind on the number of dispensaries required to support patient demand. And, at a time when the heavily financed Adult-Use campaign is supporting the vote on the November ballot, vertical licenses are pending to be issued to 22 of 72 certified applicants. This is an option for a pending Florida cannabis license available to you now!
AVAILABLE IN OTHER MARKETS
MARYLAND
Dispensary License, Paper
Washington DC metro area.
Dispensary
$10 million-plus topline. Washington DC metro area.
NEW YORK
Dispensary Licenses, Paper (2)
Dispensary Opening Soon
Albany metro area. Built out, ready to open. Big box retails nearby. High traffic counts.
Approved Dispensary Locations & Licenses
Manhattan
3.3K sf in Midtown. High traffic and visibility.
Morrisville
New Hartford
Potsdam
Rochester
Tier 2 Cultivation Location & License
22K sf building. Syracuse.
MICHIGAN
Where the volume of cannabis products sold now exceeds even Calfornia
Four Dispensaries
Leading brand. Operationally efficient. 2024 projected net revenue of $8.5 million, adjusted EBITDA of $1.4 million, and positive operating cash flow of $600K. Includes real estate.
COMING SOON
PENNSYLVANIA
Cultivation & Processor
Approximately 25K sf canopy.
Multiple Dispensaries Package
MASSACHUSETTS
Operating Vertical
Profitable.
Please let me know when you would like more information about any of these opportunities. And, let me know if you’re able to meet at the upcoming Benzinga Capital Conference to discuss details.
Thank you, David
Get the Highway EDGE on vital markets for your portfolio.
Highway 33 is a capital advisory firm capable of handling global transactions. We thrive in fiercely competitive and highly regulated industries. Including but not limited to: pharma, biotech, healthcare, cannabis, CBD/hemp and ancillary technology companies. highway 33 capital advisory
highway 33 capital advisory
highway 33 capital advisory
Technology
In IT, SaaS companies are projected to generate $287.3 billions in revenue next year. There is a very powerful reason that has special significance for investors – since with over 80% of all enterprise workloads now shifted to the cloud. It won’t be long before companies are running solely on SaaS.
Well-structured capital requires a solid foundation.
Highway 33 is a boutique capital advisory firm that specializes in structuring mergers and acquisitions as well as debt and equity fundraising transactions. Our skill set is unique. Our industry-domain experience is deep. We specialize in preparing and introducing well-vetted Investment opportunities to a network of high net-worth individuals, family offices, private equity firms, venture capitalists and specialty-focused funds.
We specialize. Structure capital.
And vet, vet, vet.
We excel in highly regulated industries. Structuring capital needs for clients in pharma, biotech, healthcare, cannabis, CBD/hemp and ancillary technologies. We drive growth and enterprise valuations for our clients through M&A, non-dilutive debt financing and/or capital investments ranging from $5M to $100M+. Since our industries of specialization are known for volatility and risk, we serve companies who have established clear market-leadership potential. And have “passed” our thorough vetting process.
For solutions that come from everywhere, start here.
Because we’re independent, we can offer unbiased strategic direction, delivered by a uniquely skilled team. Our areas of expertise cover virtually every aspect of business and industry – investment, operations, legal and public policy, engineering, finance, research, even marketing. And all of our experience is available, at a moment’s notice, to help you define and attain your investment objectives in the industries we know best – including the new frontier of the cannabis marketplace.
We exist to structure and secure capital.
For innovative industries.
Highway 33 Capital Advisory team provides the consultation and capital-structure services to build leadership brands in the biotech, pharmaceutical, health tech and cannabis industries, including in legal medical and adult-use recreational markets. Our services include the acquisition of growth and expansion capital, M&A transactions, product licensing and distribution agreements.
We know canna. We know capital.
Introducing our new Canna Debt Fund. Canna needs capital. Lack thereof is the biggest stumbling block to incredible growth since government regs. The Fund’s target return is 9.65% annually to investors. Our primary market focus is cannabis, hemp/CBD, biomass purchases for extractors, and financing commercial real estate, equipment and short-term working capital needs of licensed growers, extractors and retailers. Interested?
Industry insights to give you an edge.
Trends. Who’s investing where. Why. And what’s next. Keep up to date with changing times and changing markets. Be ahead of the curve. Get the Edge by subscribing to our weekly newsletter featuring industry viewpoints and unique investment opportunities: